Condition
Non-malignant Disorders
Total Trials
3
Recruiting
3
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
P 1 (2)
Trial Status
Recruiting3
Clinical Trials (3)
Showing 3 of 3 trials
NCT06861257Recruiting
Treosulfan Therapeutic Drug Monitoring in Pediatric Hematopoietic Stem Cell Transplant Recipients
NCT00920972Phase 1Recruiting
Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
NCT03128996Phase 1Recruiting
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Showing all 3 trials